Literature DB >> 15662552

Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study.

B Balkau1, G Hu, Q Qiao, J Tuomilehto, K Borch-Johnsen, K Pyörälä.   

Abstract

AIMS/HYPOTHESIS: Risk scores have been developed to predict cardiovascular or coronary risk, and while most have included diabetes as a risk factor, none have included lower glucose concentrations, either at fasting or following a 2-h oral glucose tolerance test. This article develops 5- and 10-year risk scores for cardiovascular mortality that include glucose concentrations as well as known diabetes status.
METHODS: Data is from the DECODE cohort: 16,506 men and 8,907 women from 14 European studies. The risk factors studied were as follows: age, fasting and 2-h glucose (including cases of known diabetes), fasting glucose alone (including cases of known diabetes), cholesterol, smoking status, systolic blood pressure and BMI. For an absolute risk score the 1995 country- and sex-specific cardiovascular death rates were used.
RESULTS: In men, for both 5- and 10-year cardiovascular mortality, after adjusting for age and study centre, all studied risk factors, except BMI, were significantly associated with cardiovascular mortality (p<0.05). These results were unchanged in multivariate models with all factors included. In women, after adjusting for age and centre, glucose categories, systolic blood pressure and BMI were predictive of 5-year cardiovascular mortality. With all factors in the model, only age and glucose categories were predictive. In terms of 10-year cardiovascular mortality, smoking status and blood pressures were also predictive in the women. For men and women, the same scores were used for the risk factors, except for age and glucose categories where the hazard ratios differed significantly. CONCLUSIONS/
INTERPRETATION: Including glucose concentrations as well as diabetic status provides quantitative information on cardiovascular risk prediction.

Entities:  

Mesh:

Year:  2004        PMID: 15662552     DOI: 10.1007/s00125-004-1574-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  36 in total

1.  An updated coronary risk profile. A statement for health professionals.

Authors:  K M Anderson; P W Wilson; P M Odell; W B Kannel
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

2.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

3.  Coronary heart disease risk assessment in diabetes mellitus--a comparison of PROCAM and Framingham risk assessment functions.

Authors:  F L Game; A F Jones
Journal:  Diabet Med       Date:  2001-05       Impact factor: 4.359

4.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

5.  The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.

Authors:  M Coutinho; H C Gerstein; Y Wang; S Yusuf
Journal:  Diabetes Care       Date:  1999-02       Impact factor: 19.112

6.  The coronary profile: 12-year follow-up in the Framingham study.

Authors:  W B Kannel; W P Castelli; P M McNamara
Journal:  J Occup Med       Date:  1967-12

7.  High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study.

Authors:  B Balkau; M Shipley; R J Jarrett; K Pyörälä; M Pyörälä; A Forhan; E Eschwège
Journal:  Diabetes Care       Date:  1998-03       Impact factor: 19.112

8.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

Authors: 
Journal:  Arch Intern Med       Date:  2001-02-12

9.  Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes.

Authors:  G Hu
Journal:  Diabetologia       Date:  2003-05-15       Impact factor: 10.122

10.  The Framingham prediction rule is not valid in a European population of treated hypertensive patients.

Authors:  Sylvie Bastuji-Garin; Anne Deverly; Dominique Moyse; Alain Castaigne; Giuseppe Mancia; Peter W de Leeuw; Luis M Ruilope; Talma Rosenthal; Gilles Chatellier
Journal:  J Hypertens       Date:  2002-10       Impact factor: 4.844

View more
  39 in total

1.  The impact of liver fat vs visceral fat in determining categories of prediabetes.

Authors:  K Kantartzis; J Machann; F Schick; A Fritsche; H-U Häring; N Stefan
Journal:  Diabetologia       Date:  2010-01-23       Impact factor: 10.122

Review 2.  Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making.

Authors:  Gerhard H Scholz; Holger Fleischmann
Journal:  Ther Adv Endocrinol Metab       Date:  2014-10       Impact factor: 3.565

Review 3.  The role of endothelial insulin signaling in the regulation of glucose metabolism.

Authors:  Tetsuya Kubota; Naoto Kubota; Takashi Kadowaki
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

4.  Haemoglobin A1c levels and subsequent cardiovascular disease in persons without diabetes: a meta-analysis of prospective cohorts.

Authors:  R Santos-Oliveira; C Purdy; M Pereira da Silva; A M dos Anjos Carneiro-Leão; M Machado; T R Einarson
Journal:  Diabetologia       Date:  2011-02-22       Impact factor: 10.122

Review 5.  Cardiovascular risk.

Authors:  Rupert A Payne
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

Review 6.  Cardiovascular disease in diabetes: where does glucose fit in?

Authors:  Jane E B Reusch; Cecilia C Low Wang
Journal:  J Clin Endocrinol Metab       Date:  2011-05-18       Impact factor: 5.958

7.  Derivation and validation of a new cardiovascular risk score for people with type 2 diabetes: the new zealand diabetes cohort study.

Authors:  C Raina Elley; Elizabeth Robinson; Tim Kenealy; Dale Bramley; Paul L Drury
Journal:  Diabetes Care       Date:  2010-03-18       Impact factor: 17.152

Review 8.  Cardiovascular risk stratification and management in pre-diabetes.

Authors:  Kristine Færch; Dorte Vistisen; Nanna Borup Johansen; Marit Eika Jørgensen
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

Review 9.  Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies.

Authors:  Theodore Mazzone; Alan Chait; Jorge Plutzky
Journal:  Lancet       Date:  2008-05-24       Impact factor: 79.321

Review 10.  Cardiovascular risk assessment scores for people with diabetes: a systematic review.

Authors:  P Chamnan; R K Simmons; S J Sharp; S J Griffin; N J Wareham
Journal:  Diabetologia       Date:  2009-07-24       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.